Votrient 400 mg (Pazopanib)

Active Ingredient: Pazopanib
Dosage Form: Tablet
Available Strength: 400mg
Manufacturer: GlaxoSmithKline Pharmaceuticals Ltd
Packaging: 30 tablets in 1 strip
Therapeutic Use: Kidney cancer, Soft tissue sarcoma
Pack Insert/Leaflet: Yes
Production Capacity: 1 Million Tablet's/Month

Description